×
About 88,585 results

Walgreens quarterly profit beats estimates on healthcare business boost
https://www.reuters.com/article/walgreens-boots-results/walgreens-quarterly-profit-beats-estimates-on-healthcare-business-boost-idUSL4N3602EF

Mar 28th, 2023 - March 28 (Reuters) - Walgreens Boots Alliance Inc’s quarterly profit beat Wall Street expectations on Tuesday, on greater contribution from its fledgling healthcare business that operates doctor clinics among others. Excluding one-off items, the company reported earnings of $1.16 per share for the quarter ended February, higher than the average analyst estimate of $1.10 per share, according to ...

COVID-19 vaccination fatigue on the rise: Researchers analyze measures aimed at increasing booster uptake
https://www.eurekalert.org/news-releases/984156

Mar 28th, 2023 - With vaccination fatigue growing and the emergence of new coronavirus variants a possibility, health officials face a potential challenge when it comes to encouraging the public to get regular boosters to protect them against Covid-19. Against this backdrop, researchers from the Medical University of Vienna (MedUni Vienna) teamed up with colleagues from the University of Vienna and the Universi...

Discovery of drug candidate that neutralizes SARS-CoV-2 could reduce length of infection upon exposure
https://www.eurekalert.org/news-releases/984222

Mar 28th, 2023 - The discovery of a small molecule in the research lab of Bradley McConnell, professor of pharmacology at the University of Houston College of Pharmacy, may well be the genesis of new medication which could shorten the course of the SARS-CoV-2 virus. Unlike Pfizer’s antiviral treatment Paxlovid, which is only useful during the first three days of showing symptoms, this possible new medication co...

Functional Neurological Disorder Emerges After COVID Infection, Vaccines
https://www.medpagetoday.com/neurology/longcovid/103708

Mar 24th, 2023 - Patients with functional neurologic disorder (FND) after SARS-CoV-2 infection had different symptoms than people with FND after COVID vaccines, retrospective data showed. Patients with post-COVID FND tended to be older, had more insidious onset, and had higher disability, according to Araceli Alonso-Canovas, MD, PhD, of Hospital Universitario Ramón y Cajal in Madrid, and co-authors. Those with ...

Heated tobacco products make SARS‑CoV‑2 infection and severe COVID‑19 more likely
https://www.eurekalert.org/news-releases/983724

Mar 24th, 2023 - Heated tobacco products—an alternative to traditional cigarettes, similar to e-cigarettes or vapes—do not burn tobacco leaves, but rather allow users to inhale the vapor produced by heating the tobacco leaves. Users choose heated tobacco products to avoid the smoke and odor of burnt tobacco as well as the expectation that they pose fewer health risks than traditional cigarettes. However, the lo...

COVID-19 Vaccine Effectiveness
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/734303

COVID-19 Vaccine Effectiveness

Overview of COVID-19 Vaccines
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/734304

Overview of COVID-19 Vaccines

Pfizer-BioNTech Bivalent Booster Authorized for Kids Under 5 Years
https://www.clinicaladvisor.com/home/topics/pediatrics-information-center/pfizer-biontech-bivalent-booster-authorized-for-kids-under-5-years/
Clinical Advisor

Mar 22nd, 2023 - The Food and Drug Administration (FDA) has authorized the use of the bivalent Pfizer-BioNTech COVID-19 vaccine as a booster dose for children 6 months through 4 years of age. This age group is now eligible to receive the booster dose at least 2 months after they complete primary vaccination with 3 doses of the monovalent Pfizer-BioNTech COVID-19 vaccine. The authorization is supported by previo...

End of COVID Emergency Will Usher in Changes Across the US Health System
https://www.clinicaladvisor.com/home/topics/infectious-diseases-information-center/end-covid-emergency-changes-us-health/
Clinical Advisor

Mar 22nd, 2023 - Kaiser Health News — The Biden administration’s decision to end the COVID-19 public health emergency in May will institute sweeping changes across the health care system that go far beyond many people having to for COVID tests. In response to the pandemic, the federal government in 2020 suspended many of its rules on how care is delivered. That transformed essentially every corner of American h...

Journal of Pharmaceutical Analysis articles spot drug targets for key pathophysiologies
https://www.eurekalert.org/news-releases/983571

Mar 22nd, 2023 - As the search for high-quality pharmaceutical drugs continues, researchers also continue spending countless hours discovering the underlying mechanisms of drug action. Knowing various pathophysiological mechanisms dramatically expedites the process of drug discovery. A recent example includes the discovery of the broad-spectrum anti-inflammatory effects of inosine, a nucleoside found in transfe...

Research shows link between child emotional difficulties and family strain during coronavirus lockdowns
https://www.eurekalert.org/news-releases/983684

Mar 22nd, 2023 - UK families were more likely to report difficulties living together during the coronavirus lockdowns than those in Turkey, a new study shows. The research shows the impact of the pandemic on parents and children at the times they were required to stay at home. Caregivers in Turkey were more concerned about contracting coronavirus. The study was carried out by Evren Morgül and Cecilia A. Essau f...

Declassifying COVID Origin Info; 'Survival Guide for Humanity'; New Quantum Computer
https://www.medpagetoday.com/infectiousdisease/covid19/103623

Mar 21st, 2023 - Note that some links may require subscriptions. President Joe Biden signed a bill requiring the declassification of information related to the origins of the COVID-19. (Reuters) The DEA issued an alert regarding the widespread threat of fentanyl mixed with the veterinary tranquilizer xylazine. The world's top climate scientists have issued "a survival guide for humanity". (CNBC) Current and for...

COVID-19 is associated with an increased risk to develop gastrointestinal disorders
https://www.eurekalert.org/news-releases/983238

Mar 20th, 2023 - COVID-19 is associated with an increased risk of developing long-term gastrointestinal disorders, including irritable bowel syndrome. This is what has been shown by a research published in the journal Gut, carried out by scholars of the University of Bologna and the IRCCS AOU S.Orsola Bologna. "The data we collected show that those who have contracted COVID-19 experience gastrointestinal sympto...

COVID-19 Forecasting and Mathematical Modeling
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/733873

Forecasts from a variety of modeling teams are combined to provide a picture of what may happen in the future.

Paxlovid associated with lower risk of hospital admission
https://www.eurekalert.org/news-releases/983030

Mar 16th, 2023 - PASADENA, Calif. — A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity or age. The study was published March 15, 2023, in Lancet ID. “Among Kaiser Permanente members in Southern California who tested positive for coronavirus...

New study from Japan shows SARS-CoV-2 Omicron XBB.1.5 variant is highly transmissible and infectious
https://www.eurekalert.org/news-releases/982316

Mar 15th, 2023 - COVID-19 has caused significant global panic after its rapid emergence more than 3 years ago. Although we now have highly effective vaccines against the SARS-CoV-2 virus, which causes COVID-19, scientists continue to study emerging SARS-CoV-2 variants in order to safeguard public health and devise global preventive strategies against emerging variants. A team led by Japanese researchers has rec...

Pfizer's COVID drug data supports use in high-risk patients - FDA staff
https://www.reuters.com/article/health-coronavirus-pfizer-fda/trial-data-supports-pfizers-covid-drug-for-high-risk-adults-fda-staff-idUSL4N35M387

Mar 14th, 2023 - (Reuters) -The U.S. health regulator’s staff reviewers said on Tuesday data from Pfizer Inc’s COVID-19 drug trials support its use in adults at high risk of progressing to severe disease, bringing the pill closer to a full approval. The Food and Drug Administration made its assessment in briefing documents ahead of a meeting of the agency’s external advisers on Thursday to discuss full approval...

Long COVID or Post-COVID Conditions
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/734181

Long COVID or Post-COVID Conditions

Caring for People with Post-COVID Conditions
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/426903

Caring for People with Post-COVID Conditions

ASL - When to Get Medical Care for COVID-19
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/733696

When to Get Medical Care for COVID-19 in American Sign Language This video can also be viewed at https://www.cdc.gov/video/socialmedia/316132-D_ParentsSupportingChildren_COVID19_ASL.mp4